Actively Recruiting
To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China.
Led by Zhejiang Cancer Hospital · Updated on 2026-01-16
200
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To investigate the real-world efficacy and safety of Sacituzumab govitecan for HER2 negative metastatic breast cancer patients in China.
CONDITIONS
Official Title
To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 18 to 75 years
- Diagnosis of locally recurrent or metastatic breast cancer suitable for chemotherapy confirmed by tissue analysis
- HER2-negative breast cancer as defined by 2018 ASCO/CAP guidelines
- Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 2
- Life expectancy of at least 12 weeks
- At least one measurable tumor lesion according to RECIST 1.1 criteria
- Received at least two cycles of Sacituzumab govitecan treatment
- Signed informed consent form
You will not qualify if you...
- Patients who have not received at least two cycles of Sacituzumab govitecan treatment
- Diagnosis of other malignant tumors in the past five years, except for cured cervical carcinoma in situ, skin basal cell carcinoma, or skin squamous cell carcinoma
- Female patients who are pregnant or breastfeeding
- Women of childbearing age with a positive pregnancy test or unwilling to use effective contraception during the study
- History of neurological or psychiatric disorders
- Any other condition deemed unsuitable for participation by the researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Actively Recruiting
Research Team
X
Xiaojia Wang, PhD
CONTACT
H
Huanhuan ZHOU, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here